Marc Vanderheyden
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marc Vanderheyden has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Jozef Bartunek
Cardiovascular Center Aalst, OLV Hospital, Aalst, Belgium
4 shared publications - Aaron Peace
Western Health and Social Care Trust, C-TRIC, Ulster University Northern Ireland, UK
3 shared publications - Bernard De Bruyne
Department of Cardiology, Lausanne University Hospital (CHUV) , Rue du Bugnon 46, CH-1011 Lausanne
3 shared publications - Emanuele Barbato
Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00185 Roma, Italy
3 shared publications - Etienne Puymirat
Cardiovascular Department, Hôpital Européen Georges-Pompidou, Université Paris-Cité, France (E.P., C.S., E.M.).
3 shared publications - Fabio Mangiacapra
Unit of Cardiac Sciences, Department of Medicine, Campus Bio-Medico University of Rome, 00128 Rome, Italy
3 shared publications
Latest Publications
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 5
014 Five-year clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stenting
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 5
014 Five-year clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stenting
- 7 December 2011
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 5 (2) , 127-134
Cellular Electrophysiological Abnormalities in Dyssynchronous Hearts and During CRT
To date, cardiac resynchronization therapy remains the only treatment that enhances systolic function while improving long-term outcome and survival. Dyssynchronous heart failure is characterized by profound global as well as regional cellular and molecular changes, many of which are not observed in synchronous heart failure. The beneficial effects of CRT on myofilament function, G protein-coupled receptor signaling, and adrenergic response are important components for restoring cardiac reserve and reducing arrhythmia, both major limitations in heart failure. Here, we review the molecular alterations associated with dyssynchronous heart failure and their reversibility induced by cardiac resynchronization therapy.
- 7 December 2011
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 5 (2) , 127-134
Cellular Electrophysiological Abnormalities in Dyssynchronous Hearts and During CRT
To date, cardiac resynchronization therapy remains the only treatment that enhances systolic function while improving long-term outcome and survival. Dyssynchronous heart failure is characterized by profound global as well as regional cellular and molecular changes, many of which are not observed in synchronous heart failure. The beneficial effects of CRT on myofilament function, G protein-coupled receptor signaling, and adrenergic response are important components for restoring cardiac reserve and reducing arrhythmia, both major limitations in heart failure. Here, we review the molecular alterations associated with dyssynchronous heart failure and their reversibility induced by cardiac resynchronization therapy.
- 1 January 2009
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 47 (3) , 248-52
Dipeptidyl-peptidase IV and B-type natriuretic peptide. From bench to bedside
B-type natriuretic peptide (BNP) has emerged as a reliable biomarker in patients with congestive heart failure. The mature, biologically active B-type natriuretic peptide, BNPClin Chem Lab Med 2009;47:248–52.
- 1 January 2009
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 47 (3) , 248-52
Dipeptidyl-peptidase IV and B-type natriuretic peptide. From bench to bedside
B-type natriuretic peptide (BNP) has emerged as a reliable biomarker in patients with congestive heart failure. The mature, biologically active B-type natriuretic peptide, BNPClin Chem Lab Med 2009;47:248–52.
- 1 January 2005
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 6 (1) , 47-53
Non-invasive assessment of coronary flow reserve in idiopathic dilated cardiomyopathy: hemodynamic correlations
Impaired vasodilator myocardial blood flow response has been observed in dilated cardiomyopathy (DCMP). However, the mechanisms responsible for this blunted response are not clear. In the present study, we investigated whether the blunted vasodilator flow response is related to indices of left ventricular performance in patients with idiopathic dilated cardiomyopathy. Eighteen DCMP patients and 12 healthy subjects (C) underwent transoesophageal echocardiography within 48 h from cardiac catheterization. Coronary flow velocity reserve (CFR) was measured in the proximal LAD as the ratio of the peak diastolic coronary flow velocity (Vd-M) after intravenous administration of adenosine to peak baseline diastolic flow velocity (Vd-R). Left ventricular (LV) mass index was positively correlated with baseline coronary diastolic velocity (r=0.415; p=0.043) and inversely correlated with coronary flow reserve (r=-0.570; p=0.003). The baseline coronary diastolic velocity was higher in DCMP vs C (56+/-13 cm/s vs 35+/-12 cm/s; p=0.04). In DCMP pts Vd-R positively correlated with end-diastolic wall stress (r=0.654; p=0.01). Vd increased in both C (96+/-32 cm/s; p<0.05 vs baseline) and DCMP patients (108+/-20 cm/s; p<0.01 vs baseline). The CFR was lower in DCMP patients vs C (1.93+/-0.78 vs 2.99+/-1.01; p=0.009). In DCMP pts CFR was negatively correlated with right atrial pressure (r=-0.595; p=0.015), LVEDP (r=-0.576; p=0.015), pulmonary capillary wedge pressure (PCWP: r=-0.772; p<0.001) and positively with ejection fraction (EF: r=0.683; p=0.003). Pts with DCMP have lower CFR compared to controls. This blunted CFR is due to higher baseline coronary flow and reflects higher wall stress. The close relation between CFR and EF, PCWP and LVEDP suggests that not only a higher baseline Vd but also compressive forces due to left ventricular dysfunction might be responsible for the observed blunted adenosine-mediated coronary vasodilation.
- 1 January 2005
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 6 (1) , 47-53
Non-invasive assessment of coronary flow reserve in idiopathic dilated cardiomyopathy: hemodynamic correlations
Impaired vasodilator myocardial blood flow response has been observed in dilated cardiomyopathy (DCMP). However, the mechanisms responsible for this blunted response are not clear. In the present study, we investigated whether the blunted vasodilator flow response is related to indices of left ventricular performance in patients with idiopathic dilated cardiomyopathy. Eighteen DCMP patients and 12 healthy subjects (C) underwent transoesophageal echocardiography within 48 h from cardiac catheterization. Coronary flow velocity reserve (CFR) was measured in the proximal LAD as the ratio of the peak diastolic coronary flow velocity (Vd-M) after intravenous administration of adenosine to peak baseline diastolic flow velocity (Vd-R). Left ventricular (LV) mass index was positively correlated with baseline coronary diastolic velocity (r=0.415; p=0.043) and inversely correlated with coronary flow reserve (r=-0.570; p=0.003). The baseline coronary diastolic velocity was higher in DCMP vs C (56+/-13 cm/s vs 35+/-12 cm/s; p=0.04). In DCMP pts Vd-R positively correlated with end-diastolic wall stress (r=0.654; p=0.01). Vd increased in both C (96+/-32 cm/s; p<0.05 vs baseline) and DCMP patients (108+/-20 cm/s; p<0.01 vs baseline). The CFR was lower in DCMP patients vs C (1.93+/-0.78 vs 2.99+/-1.01; p=0.009). In DCMP pts CFR was negatively correlated with right atrial pressure (r=-0.595; p=0.015), LVEDP (r=-0.576; p=0.015), pulmonary capillary wedge pressure (PCWP: r=-0.772; p<0.001) and positively with ejection fraction (EF: r=0.683; p=0.003). Pts with DCMP have lower CFR compared to controls. This blunted CFR is due to higher baseline coronary flow and reflects higher wall stress. The close relation between CFR and EF, PCWP and LVEDP suggests that not only a higher baseline Vd but also compressive forces due to left ventricular dysfunction might be responsible for the observed blunted adenosine-mediated coronary vasodilation.
- 12 July 2002
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 56 (4) , 522-526
Thrombosis of a patent foramen ovale closure device: Thrombolytic management
Transcatheter closure of a patent foramen ovale (PFO) offers a valuable alternative to surgery in selected patients with presumed paradoxical embolism. Like for all other devices, several complications have been described. Although the majority of these complications are caused by technical problems of the device itself, thrombosis is a relatively infrequent but feared finding, as it may result in recurrent embolic events and persistent neurological deficits. The majority of the complications after implantation are dealt with by surgical removal of the device and subsequent surgical closure of the PFO. The present case report describes biatrial thrombosis of a PFO device that was successfully treated with thrombolytics and GP IIb/IIIa receptor blockers. In stable patients, this pharmaco‐therapeutic approach should be attempted to save the thrombosed PFO device and could therefore offer a valuable alternative to surgical removal of the device. Cathet Cardiovasc Intervent 2002;56:522–526.
- 12 July 2002
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 56 (4) , 522-526
Thrombosis of a patent foramen ovale closure device: Thrombolytic management
Transcatheter closure of a patent foramen ovale (PFO) offers a valuable alternative to surgery in selected patients with presumed paradoxical embolism. Like for all other devices, several complications have been described. Although the majority of these complications are caused by technical problems of the device itself, thrombosis is a relatively infrequent but feared finding, as it may result in recurrent embolic events and persistent neurological deficits. The majority of the complications after implantation are dealt with by surgical removal of the device and subsequent surgical closure of the PFO. The present case report describes biatrial thrombosis of a PFO device that was successfully treated with thrombolytics and GP IIb/IIIa receptor blockers. In stable patients, this pharmaco‐therapeutic approach should be attempted to save the thrombosed PFO device and could therefore offer a valuable alternative to surgical removal of the device. Cathet Cardiovasc Intervent 2002;56:522–526.
- 1 July 2002
- Vol. 18 (7) , 759-61
Symptomatic atraumatic dissection of a left internal mammary artery graft five years after coronary artery bypass graft surgery.
The case of a spontaneous dissection of a left internal mammary artery grafted on to the diagonal branch and the left anterior descending artery is reported. The clinical and diagnostic features of this condition are discussed. Despite an extensive literature search, no such case was found. The present case is the first to be reported. It was speculated that extensive kinking of the left internal mammary artery contributed to the pathogenesis of this syndrome.
- 1 July 2002
- Vol. 18 (7) , 759-61
Symptomatic atraumatic dissection of a left internal mammary artery graft five years after coronary artery bypass graft surgery.
The case of a spontaneous dissection of a left internal mammary artery grafted on to the diagonal branch and the left anterior descending artery is reported. The clinical and diagnostic features of this condition are discussed. Despite an extensive literature search, no such case was found. The present case is the first to be reported. It was speculated that extensive kinking of the left internal mammary artery contributed to the pathogenesis of this syndrome.
- 1 April 2002
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 25 (4) , 511-512
Intoxication with Taxus Baccata: Cardiac Arrhythmias Following Yew Leaves Ingestion
WILLAERT, W., et al.: Intoxication with Taxus Baccata: Cardiac Arrhythmias Following Yew Leaves In‐gestion. The use of yew leaves (Taxus Baccata) as a means of deliberate self‐harm is infrequent. The potent effect of the toxin is primarily cardiac and results in rhythm alterations and ultimately ventricular fibrillation. As there is no known antidote, and classic antiarrhythmic therapy proves to be ineffective, a prompt diagnosis is of great importance as immediate supportive action is the only valuable alternative. This case describes a 43‐year‐old women who attempted suicide by ingesting the leaves of Taxus Baccata. We discuss the effects and the difficulty of treatment associated with yew leaf poisoning.
- 1 April 2002
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 25 (4) , 511-512
Intoxication with Taxus Baccata: Cardiac Arrhythmias Following Yew Leaves Ingestion
WILLAERT, W., et al.: Intoxication with Taxus Baccata: Cardiac Arrhythmias Following Yew Leaves In‐gestion. The use of yew leaves (Taxus Baccata) as a means of deliberate self‐harm is infrequent. The potent effect of the toxin is primarily cardiac and results in rhythm alterations and ultimately ventricular fibrillation. As there is no known antidote, and classic antiarrhythmic therapy proves to be ineffective, a prompt diagnosis is of great importance as immediate supportive action is the only valuable alternative. This case describes a 43‐year‐old women who attempted suicide by ingesting the leaves of Taxus Baccata. We discuss the effects and the difficulty of treatment associated with yew leaf poisoning.